Results 211 to 220 of about 1,252,849 (358)

Plerixafor plus granulocyte colony-stimulating factor for patients with non-Hodgkin lymphoma and multiple myeloma: Long-term follow-up report [PDF]

, 2018
Bolwell, Brian, Cheverton, Peter D, DiPersio, John F, Horwitz, Mitchell E, Kaufman, Jonathan L, Maziarz, Richard T, McCarty, John M, Micallef, Ivana N, Nademanee, Auayporn P, Stadtmauer, Edward A, Stiff, Patrick J, Struijs, Martin, Vargo, Rita   +12 more
core   +2 more sources

A liberalized diet does not improve caloric intake during neutropenia in patients undergoing hematopoietic stem cell transplants: A prospective randomized controlled trial

Nutrition in Clinical Practice, EarlyView.
Abstract Background The neutropenic diet has been a long‐standing approach to preventing infection in patients with hematopoietic stem cell transplants (HSCTs), although data on its efficacy are inconclusive and its restrictive nature might contribute to harm by reducing dietary intake in this patient population who typically experiences poor oral ...
Jenna N. Schulz, Kristina H. McGee, Michael T. Weaver, John R. Wingard, Precious D. Williams, Christina L. Cline, Nosha Farhadfar, Debra Lynch‐Kelly, Zeina A. Al‐Mansour, Wendy J. Dahl   +9 more
wiley   +1 more source

Autologous glueless simple oral mucosal transplantation for the repair of limbal stem cell deficiency ocular surface in a rabbit model. [PDF]

Sci Rep
Zhang K, Liu W, Ren X, Yin Y, Chen W, Chen F, Zhu J, Shen L.   +7 more
europepmc   +1 more source

Adult Acute Megakaryoblastic Leukemia in a Mantle Cell Lymphoma Post Treatment and Auto‐Transplant

The Kaohsiung Journal of Medical Sciences, EarlyView.
Chin‐Mu Hsu, Bi‐Hua Du, Chien Hsiao, Hui‐Hua Hsiao   +3 more
wiley   +1 more source

Barriers to Hematopoietic Stem Cell Transplant Among Caregivers and Adolescents With Sickle Cell Disease

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Hematopoietic stem cell transplantation (HSCT) is a curative treatment for sickle cell disease (SCD). However, barriers exist that prevent access to this treatment modality. Methods An IRB‐approved mixed‐method survey of barriers to HSCT in SCD was given to parents, caregivers, and adolescents obtaining care at the Children's of ...
Chibuzo Ilonze, Alexandria Broadnax, Hilary Haines, Jeffrey Lebensburger, Frederick Goldman   +4 more
wiley   +1 more source

Developing Mouse Models for Ovarian Tissue Transplantation and Xenotransplantation: A Review. [PDF]

Med Sci Monit
Liu FX, Lin Z, Huang KL.
europepmc   +1 more source

Investigating Local Sequence‐Structural Attributes of Amyloidogenic Light Chain Variable Domains

Proteins: Structure, Function, and Bioinformatics, EarlyView.
ABSTRACT Light chain amyloidosis is a medical condition characterized by the aggregation of misfolded antibody light chains into insoluble amyloid fibrils in the target organs, causing organ dysfunction, organ failure, and death. Despite extensive research to understand the factors contributing to amyloidogenesis, accurately predicting whether a given ...
Puneet Rawat, R. Prabakaran, Divya Sharma, Vasanth Mandala, Victor Greiff, Sandeep Kumar, M. Michael Gromiha   +6 more
wiley   +1 more source

Autologous serum supplementation promotes the phenotype maintenance of human chondrocytes with increased cellular autophagy. [PDF]

Sci Rep
Yin W, Qian Z, Liu C, Song B, Sun Q.
europepmc   +1 more source

Human Dermal Microvascular Arterial and Venous Blood Endothelial Cells and Their Use in Bioengineered Dermo‐Epidermal Skin Substitutes

Small Methods, EarlyView.
This study unveils a pioneering approach to bioengineering of human skin substitutes with distinct arterial and venous capillaries. Combining single‐cell transcriptomics and 3D hydrogel models, this work reveals unique endothelial marker dynamics in fetal and juvenile skin.
Dominic Rütsche, Monica Nanni, Phil Cheng, Nicolà Caflisch, Aizhan Tastanova, Céline Jenni, Mitchell P. Levesque, Ueli Moehrlen, Agnes S. Klar, Thomas Biedermann   +9 more
wiley   +1 more source

Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets

European Journal of Neurology, Volume 30, Issue 1, Page 179-186, January 2023., 2023
Brain atrophy measures can reliably assess the effects of treatment in patients with multiple sclerosis. Using a robust longitudinal method, we demonstrated that, after a short period of pseudoatrophy, treatment with cladribine tablets significantly reduced grey matter atrophy in comparison with placebo.
Rosa Cortese, Marco Battaglini, Maria Pia Sormani, Ludovico Luchetti, Giordano Gentile, Maira Inderyas, Nektaria Alexandri, Nicola De Stefano   +7 more
wiley   +1 more source